Hayward, CA, United States of America

Xiang Zhou

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Xiang Zhou: Revolutionizing Pain Treatment through Patented Innovations

Introduction: Xiang Zhou, an inventive mind based in Hayward, California, has made significant contributions to the field of pharmaceutical science with a focus on pain treatment. As an employee of Siteone Therapeutics, Inc., he has dedicated his expertise to developing innovative solutions aimed at improving the lives of those suffering from pain related to voltage-gated sodium channel dysfunction.

Latest Patents: Zhou holds a notable patent for "11,13-modified saxitoxins for the treatment of pain." This invention revolves around the development of compounds and pharmaceutical compositions that leverage 11,13-modified saxitoxins to target conditions associated with voltage-gated sodium channel function. His work outlines methods for preparing these compounds and their application in clinical settings, positioning him as a key figure in advancing pain management therapies.

Career Highlights: With one patent to his name, Xiang Zhou has established himself as a forward-thinking inventor in the pharmaceutical landscape. His research focuses on innovative methodologies that pave the way for new treatments and therapeutic interventions, particularly in the realm of pain relief.

Collaborations: Throughout his career, Zhou has collaborated with notable colleagues, including Hassan Pajouhesh and John Mulcahy. These partnerships exemplify the collaborative spirit of research innovation within Siteone Therapeutics, Inc., as they work together in pursuit of groundbreaking advancements in medical science.

Conclusion: Xiang Zhou's contributions to the field of pharmaceuticals are marked by his innovative patent aimed at transforming pain treatment practices. His work at Siteone Therapeutics, Inc. and collaborations with fellow researchers highlight a commitment to developing effective therapies that harness the potential of modified saxitoxins. With his dedication and inventive spirit, Zhou is poised to make lasting impacts in pain management and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…